We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Curcumin-based-fluorescent probes targeting ALDH1A3 as a promising tool for glioblastoma precision surgery and early diagnosis.
- Authors
Gelardi, Edoardo L. M.; Caprioglio, Diego; Colombo, Giorgia; Del Grosso, Erika; Mazzoletti, Daniele; Mattoteia, Daiana; Salamone, Stefano; Ferraris, Davide M.; Aronica, Eleonora; Nato, Giulia; Buffo, Annalisa; Rizzi, Menico; Magrassi, Lorenzo; Minassi, Alberto; Garavaglia, Silvia
- Abstract
Glioblastoma (GBM) is the most aggressive primary brain tumour for which both effective treatments and efficient tools for an early-stage diagnosis are lacking. Herein, we present curcumin-based fluorescent probes that are able to bind to aldehyde dehydrogenase 1A3 (ALDH1A3), an enzyme overexpressed in glioma stem cells (GSCs) and associated with stemness and invasiveness of GBM. Two compounds are selective versus ALDH1A3, without showing any appreciable interaction with other ALDH1A isoenzymes. Indeed, their fluorescent signal is detectable only in our positive controls in vitro and absent in cells that lack ALDH1A3. Remarkably, in vivo, our Probe selectively accumulate in glioblastoma cells, allowing the identification of the growing tumour mass. The significant specificity of our compounds is the necessary premise for their further development into glioblastoma cells detecting probes to be possibly used during neurosurgical operations. Curcumin-based fluorescent probes are presented that are able to selectively bind to aldehyde dehydrogenase 1A3 (ALDH1A3), an enzyme overexpressed in glioma stem cells and specifically identify glioblastoma cells in vitro and in vivo.
- Subjects
GLIOBLASTOMA multiforme; SURGICAL diagnosis; BRAIN tumors; ALDEHYDE dehydrogenase; EARLY diagnosis
- Publication
Communications Biology, 2022, Vol 5, Issue 1, p1
- ISSN
2399-3642
- Publication type
Article
- DOI
10.1038/s42003-022-03834-7